CORONA Remedies Limited (CORONA) — Financial Results | 22 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company announces Q1 FY27 earnings conference call
💡 Investor Takeaway
Investors can attend the call to hear management discuss Q1 FY27 results.

CORONA Remedies Limited announced its Q1 FY27 earnings conference call scheduled for August 3, 2026 at 11:30 a.m. IST to discuss financial results for the quarter ended June 30, 2026, with management representation including the Managing Director, Joint Managing Director, and CFO.

📄 View Original Announcement (PDF)

About CORONA Remedies Limited (CORONA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹10,869.98 Cr

View full CORONA stock details →

📡 Get AI alerts when CORONA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CORONA — Free

📊 More CORONA filings

See all CORONA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CORONA files new disclosures

Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CORONA — Free

Free account · 2 AI queries/day